View Report Details Global Breast Cancer Market Report ----------------------------------------2015
View Report Details Executive Summary
Breast cancer is the most commonly diagnosed cancer and the leading cause of cancer deaths in women. Breast cancer knows considers no boundaries of age, gender, socioeconomic status or geographic location. Being a woman and growing older are the factors which associate maximum risk of having breast cancer.
In the past few years, the cases of breast cancer have increased tremendously in certain regions including the U.S. and the Europe. The breast cancer market is driven by various factors including aging female population, obesity and diabetes, dense breast tissues, healthcare expenditure, exposure to X-Ray and Gamma Radiations, Estrogen-Progestin Therapy (EPT) and increased consumption of alcohol and tobacco. A major trend which will probably remain prominent in the breast cancer treatment industry is the fact that innovative technologies and pharmaceutical molecules are always under development and are mostly subject to changes. Challenges associated with breast cancer are like, financial burdens associated with the treatment and adverse effects of Aromatase Inhibitors (AI) on patients.
The market for breast cancer drugs represents an area of potential opportunity in both developed and developing countries. Due to effectiveness and advancements in technology, a large number of companies are focusing to develop innovative breast cancer drugs and treatments. Further, the companies are combining businesses and spending heavily on research and development to develop effective treatment methods for breast cancer.
The present report provides a comprehensive analysis of the global breast cancer diagnosis and treatment market with focus on regions like the US, Brazil, Europe and APAC Countries. Furthermore, market dynamics such as the industry trends and development, the underlying growth drivers and major issues faced by the industry are elicited. On the contention front, the market is personified by the intense competition in terms of research and development of novel therapeutic molecules. The leading players operating in the industry include Hologic, Johnson and Johnson, Siemens AG, Roche and Novartis which are also profiled in this report.
‘Breast cancer’ defines a malignant tumor that has developed from cells in the breast… Global Oncology Drug Spending (2010-2014) 120
The global oncology drugs market increased to US$... billion in the year 2014, increasing from US$.. billion in the year 2010 registering a CAGR of …% globally over the last five years. The U.S. has the maximum share in the drugs spending on cancer making …% of the total spending. In the European Union, oncology represents …% of total drug spending. Pharmerging countries had a share of …% in 2014.
100 80
The breast cancer drugs are estimated to contribute the maximum share of …% in 2014, followed by quantitative immunofluorescence with …%. A share of ….% was contributed by genomic analysis followed by IHC/FISH with a nominal …% share.
n ilo B S$ U
60 40 20
For breast cancer in the U.S. …% are diagnosed at the local stage, ..% are diagnosed at the regional stage, and .. % are diagnosed at the distant level.
0
Global Breast Cancer Market by Segments (2014))
Breast Cancer Drugs
Quantitative Immunoflourescence
Genomic Analysis
IHC/FISH
Global Oncology Spending by Region (2014)
US
EU5
ROW
Pharmerging
Japan
Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer deaths in women. .. The U.S. Breast Imaging Systems Market (2010-2016E) The breast imaging system market earned revenues of US$.. billion in the year 2013 and is estimated to reach US$.. billion by 2014 and further reach US$.. billion by 2016 increasing at a CAGR of …%.
1.6 1.4
Total units of Digital Mammography in the U.S. for the year 2014 were … along with … facilities where the total units increased by … from the previous fiscal.
1.2 1.0
The U.S. market for Digital Breast Tomosynthesis is expected to see a significant rise in the number of units sold, increasing at an impressive CAGR of …% between 2013 and 2020.
n ilo B S$ U
0.8 0.6
The Brazilian breast cancer imaging market has grown from US$...million in 2013 to US$... million in 2014 and is further estimated to reach US$... million by the end of 2015.
0.4 0.2 0.0
The U.S. Digital Mammography Market (2010-2014)
Brazil’s Breast Cancer Imaging Market (2011-2015E) 60
16000 14000
50
12000 10000
40
8000 6000
30
n ilo M S$ U
4000 2000 0 2010
2011
2012 Facilities
Units
2013
2014
20 10 0
Ageing women are the high risk population for breast cancer as they are highly vulnerable to developing breast cancer due to hormonal imbalance… APAC - Tomography Scanners per Million People (2014)
Japan had the highest number of tomography scanners per million populations, which stood at … units for 2014, followed by Australia which had …units in the APAC region.
120
The Republic of Korea has the highest number of mammography units per million female population aged …which stood at... units, followed by other countries such as Japan, New Zealand and Australia.
100 80 60
The European market for breast imaging systems is estimated to have increased from US$... million in 2013 to approximately US$... billion in 2014 and further increase to US$... billion by the year 2020.
t a u p n ilo rM e P
40 20
Europe’s mammography market revenue is estimated to have reached US$...million in the year 2014, from US$... million in 2013.
0 Japan
Australia
New Zealand
Singapore Malaysia
Thailand
at u p n ilo erM P
APAC - MRI Units per Million People (2014) 50 45 40 35 30 25 20 15 10 5 0 Japan
Korea Republic
Australia
New Singapore Malaysia Zealand
The European Mammography Systems Market (2013-2018E)
0
50
100
150
200
US$ Million
250
300
350
Contact Us: Details View Report These are abridged and sanitized sample pages from the comprehensive report on the “ Global Breast Cancer Market ”. To know more about this report or for any customized research requirement, please contact the following:
Koncept Analytics
Vikas Gupta BD Manager
CS-36, Second Floor, Ansal Plaza Vaishali, Ghaziabad, U.P. – 201010 T. +91-120-4130959 C: +91-9811715635 vikas@konceptanalytics.com
www.konceptanalytics.com